Price target upside
Rani Therapeutics Holdings, Inc. - Class A Common Stock Price Target Upside or Downside
RANI price target upside based on the current price and analyst average.
Direct answer
Rani Therapeutics Holdings, Inc. - Class A Common Stock's analyst target implies +840%.
The average target is $7.50 compared with a recorded current price of $0.80.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 14, 2026.
Get free Rani Therapeutics Holdings, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.80
- Average price target
- $7.50
- High price target
- $11.00
- Low price target
- $5.00
- Target upside
- +840%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 14, 2026
- Valid through
- August 21, 2026